242 related articles for article (PubMed ID: 22564130)
1. Coming to terms with nonsteroidal anti-inflammatory drug gastropathy.
Roth SH
Drugs; 2012 May; 72(7):873-9. PubMed ID: 22564130
[TBL] [Abstract][Full Text] [Related]
2. Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly.
Lanas A; Ferrandez A
Drugs Aging; 2007; 24(2):121-31. PubMed ID: 17313200
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety.
Roth SH
Clin Interv Aging; 2011; 6():125-31. PubMed ID: 21753867
[TBL] [Abstract][Full Text] [Related]
4. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes.
van Leen MW; van der Eijk I; Schols JM
Age Ageing; 2007 Jul; 36(4):414-8. PubMed ID: 17537740
[TBL] [Abstract][Full Text] [Related]
5. Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners.
Pertusi RM; Godwin KS; House JK; Knebl JA; Alexander JH; Rubin BR; Forman MD
J Am Osteopath Assoc; 1999 Jun; 99(6):305-10. PubMed ID: 10405516
[TBL] [Abstract][Full Text] [Related]
6. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.
Layton D; Souverein PC; Heerdink ER; Shakir SA; Egberts AC
Drug Saf; 2008; 31(2):143-58. PubMed ID: 18217790
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.
Dubois RW; Melmed GY; Henning JM; Laine L
Aliment Pharmacol Ther; 2004 Jan; 19(2):197-208. PubMed ID: 14723611
[TBL] [Abstract][Full Text] [Related]
10. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.
Johnell K; Fastbom J
Clin Drug Investig; 2008; 28(11):687-95. PubMed ID: 18840011
[TBL] [Abstract][Full Text] [Related]
11. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs.
Scheiman JM; Fendrick AM
Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078
[TBL] [Abstract][Full Text] [Related]
12. Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial.
Ray WA; Stein CM; Byrd V; Shorr R; Pichert JW; Gideon P; Arnold K; Brandt KD; Pincus T; Griffin MR
Med Care; 2001 May; 39(5):425-35. PubMed ID: 11317091
[TBL] [Abstract][Full Text] [Related]
13. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?
Barkin RL; Beckerman M; Blum SL; Clark FM; Koh EK; Wu DS
Drugs Aging; 2010 Oct; 27(10):775-89. PubMed ID: 20883058
[TBL] [Abstract][Full Text] [Related]
14. The NSAID dilemma: managing osteoarthritis in high-risk patients.
Roth SH; Anderson S
Phys Sportsmed; 2011 Sep; 39(3):62-74. PubMed ID: 22030942
[TBL] [Abstract][Full Text] [Related]
15. The Mexican consensus on the diagnosis, treatment, and prevention of NSAID-induced gastropathy and enteropathy.
Bielsa-Fernández MV; Tamayo-de la Cuesta JL; Lizárraga-López J; Remes-Troche JM; Carmona-Sánchez R; Aldana-Ledesma JM; Avendaño-Reyes JM; Ballesteros-Amozorrutia MA; De Ariño M; de Giau-Triulzi L; Flores-Rendón R; Huerta-Guerrero H; González-González JA; Hernández-Guerrero A; Murcio-Pérez E; Jáquez-Quintana JO; Meixueiro-Daza A; Nogueira-de Rojas JR; Rodríguez-Hernández H; Santoyo-Valenzuela R; Solorzano-Olmos SC; Uscanga-Domínguez LF; Zamarripa-Dorsey F
Rev Gastroenterol Mex (Engl Ed); 2020; 85(2):190-206. PubMed ID: 32094057
[TBL] [Abstract][Full Text] [Related]
16. Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice.
Tamblyn R; Berkson L; Dauphinee WD; Gayton D; Grad R; Huang A; Isaac L; McLeod P; Snell L
Ann Intern Med; 1997 Sep; 127(6):429-38. PubMed ID: 9312999
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.
Borer JS; Simon LS
Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077
[TBL] [Abstract][Full Text] [Related]
18. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
19. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.
Naesdal J; Brown K
Drug Saf; 2006; 29(2):119-32. PubMed ID: 16454539
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: a focus on ketoprofen/omeprazole.
Gigante A; Tagarro I
Clin Drug Investig; 2012 Apr; 32(4):221-33. PubMed ID: 22350497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
